Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
18–55
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Men and women, aged 18 to 55 years, inclusive
Healthy participants as determined by a lack of clinically significant deviation from normal in medical history, physical examination, electrocardiograms, and clinical laboratory determinations
Body Mass Index of 18 to 32 kg/m\^2, inclusive
You may not be if
Any significant acute or chronic medical illness
Current or recent (within 3 months) gastrointestinal disease
Any major surgery within 4 weeks of study drug administration
History of allergy to DPP-4 inhibitors or related compounds
History of allergy or intolerance to metformin or other similar acting agents
Previous exposure to saxagliptin
Exposure to metformin within 3 months pervious to study drug administration
Estimated creatinine clearance of \<80 mL/min using the Cockcroft Gault formula
Clareo Health | Bioequivalence Study of 2.5-mg Saxagliptin and 500-mg Glucophage in Tablets and a Fixed-dose Combination Tablet in Healthy Participants
